O-Linked N-Acetylglucosamine Epitope H Expression in Placentas of Pregnancies Complicated With Fetal Growth Restriction: A Case–Control Immunochemistry Study
In Vivo · 2025
DOI: 10.21873/invivo.14150 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Agapi Karkabouna und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Embryology, University of Thessaly, Larissa, Greece. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Placenta, Epitopes, Acetylglucosamine. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Embryology, University of Thessaly, Larissa, Greece.
- Department of Embryology, University of Thessaly, Larissa, Greece; athsamara@uth.gr.
- Department of Obstetrics Gynecology, University Hospital of Larissa, Larissa, Greece.
- Department of Pathology, University of Thessaly, Larissa, Greece.
Zitieren
APA
Karkabouna, A., Samara, A. A., Zacharouli, K., Ioannou, M., Garas, A., Daponte, A., & Sotiriou, S. (2025). O-Linked N-Acetylglucosamine Epitope H Expression in Placentas of Pregnancies Complicated With Fetal Growth Restriction: A Case–Control Immunochemistry Study. In Vivo. https://doi.org/10.21873/invivo.14150
Vancouver
Karkabouna A, Samara AA, Zacharouli K, Ioannou M, Garas A, Daponte A, et al. O-Linked N-Acetylglucosamine Epitope H Expression in Placentas of Pregnancies Complicated With Fetal Growth Restriction: A Case–Control Immunochemistry Study. In Vivo. 2025. doi:10.21873/invivo.14150
BibTeX
@article{Karkabouna2025,
author = {Karkabouna, Agapi and Samara, Athina A and Zacharouli, Konstantina and Ioannou, Maria and Garas, Antonios and Daponte, Alexandros and Sotiriou, Sotirios},
title = {O-Linked N-Acetylglucosamine Epitope H Expression in Placentas of Pregnancies Complicated With Fetal Growth Restriction: A Case–Control Immunochemistry Study},
journal = {In Vivo},
year = {2025},
doi = {10.21873/invivo.14150}
}
EUVIMED